Direct-toconsumer Disease Risk and Health DNA Test Market
Direct-to-consumer Disease Risk and Health DNA
Test Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Direct-to-consumer Disease Risk and Health DNA Test Market Size and Growth
The Direct-to-consumer Disease Risk and Health DNA Test market research reports reveal a rapidly growing market driven by consumer interest in personalized healthcare and preventive medicine. The market size is projected to reach $2.5 billion by 2025, with companies investing in innovative technologies and partnerships to capitalize on this trend.
Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ 23andMe
◍ MyHeritage
◍ LabCorp
◍ Myriad Genetics
◍ Ancestry.com
◍ Quest Diagnostics
◍ Gene By Gene
◍ DNA Diagnostics Center
◍ Invitae
◍ IntelliGenetics
◍ Ambry Genetics
◍ Living DNA
◍ EasyDNA
◍ Pathway Genomics
◍ Centrillion Technology
◍ Xcode
◍ Color Genomics
◍ Anglia DNA Services
The Direct-to-consumer Disease Risk and Health DNA Test Market is highly competitive with companies like 23andMe, MyHeritage, LabCorp, Myriad Genetics, and more offering services. These companies utilize advanced genetic testing technology to provide consumers with valuable insights into their health and ancestry, driving growth in the market.
- 23andMe: $475 million in sales revenue
- MyHeritage: $100 million in sales revenue
- LabCorp: $9.5 billion in sales revenue
- Myriad Genetics: $863 million in sales revenue
Request Sample Report
Market Segmentation
By Application
◍ Online
◍ Offline
By Product
◍ Type I
◍ Celiac Disease
◍ Parkinson Disease
◍ Alzheimer Disease
◍ Other
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients